Literature DB >> 11313947

Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.

S H Jee1, S C Shen, H C Chiu, W L Tsai, M L Kuo.   

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine that is capable of modulating the diverse functions of cells such as acute phase responses and inflammation. Excessive or insufficient production of IL-6 may contribute to certain diseases of the skin. The aim of this study was to investigate the possible role of IL-6 in the tumorigenesis of basal cell carcinoma (BCC). Initially, we transfected IL-6 expression vector, under the control of a CMV promoter, into human BCC cells and successfully obtained IL-6-overexpressing clones (BCC/IL-6-c1 and BCC/IL-6-c2) and a mixture (BCC/IL-6). DNA synthesis assay determined using (3)H-thymidine pulse incorporation revealed that IL-6-expressing BCC cells exhibited a much higher DNA synthesis rate than the neo control or parental BCC cells. We also detected a greater abundance of IL-6-expressing cell colonies formed in soft agar than in the vector control cells. Furthermore, BCC/IL-6 cells, but not vector control cells, were resistant to UV and photodynamic therapy (PDT)-induced apoptosis, as confirmed using DNA fragmentation and morphologic change analyses. Immunoblot analysis showed that Mcl-1, an anti-apoptotic protein, was specifically up-regulated IL-6 transfectants but not in the control cells. Transient transfection of IL-6 transfectants with antisense mcl-1 greatly enhanced their apoptosis frequency by UV treatment. In tumorigenesis assay, IL-6 transfected clones formed tumors in nude mice more rapidly than the control cells. These tumors appeared to be highly vascularized using pathological examination. Supportive of this finding, we found that IL-6 transfected cells expressed elevated levels of two angiogenic factors, cyclooxygenase (Cox)-2 and vascular endothelial growth factor (VEGF). These results suggest that overexpression of IL-6 enhances the tumorigenic activity of BCC cells by both suppressing apoptosis and actively promoting angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313947     DOI: 10.1038/sj.onc.1204076

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Integrating pathway analysis and genetics of gene expression for genome-wide association study of basal cell carcinoma.

Authors:  Mingfeng Zhang; Liming Liang; Nilesh Morar; Anna L Dixon; G Mark Lathrop; Jun Ding; Miriam F Moffatt; William O C Cookson; Peter Kraft; Abrar A Qureshi; Jiali Han
Journal:  Hum Genet       Date:  2011-10-18       Impact factor: 4.132

2.  Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.

Authors:  Monique B Nilsson; Robert R Langley; Isaiah J Fidler
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  How do benign myoepithelial cells from in situ areas of carcinoma ex-pleomorphic adenoma favor tumor progression?

Authors:  Elizabeth Ferreira Martinez; Ney Soares de Araújo; Vera Cavalcanti de Araújo
Journal:  J Cell Commun Signal       Date:  2015-06-12       Impact factor: 5.782

4.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

Review 5.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

6.  IL-6 potentiates tumor resistance to photodynamic therapy (PDT).

Authors:  Craig M Brackett; Barbara Owczarczak; Kimberley Ramsey; Patricia G Maier; Sandra O Gollnick
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

7.  Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer.

Authors:  Khurram Rehman; Mohd Hanif Zulfakar
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

8.  Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in mice.

Authors:  Miguel Pera; Heidi Nelson; S Vincent Rajkumar; Tonia M Young-Fadok; Lawrence J Burgart
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

Review 9.  Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.

Authors:  Brooke B Ancrile; Kevin M O'Hayer; Christopher M Counter
Journal:  Mol Interv       Date:  2008-02

10.  Cadmium induces lung inflammation independent of lung cell proliferation: a molecular approach.

Authors:  Subhadip Kundu; Suman Sengupta; Soumya Chatterjee; Soham Mitra; Arindam Bhattacharyya
Journal:  J Inflamm (Lond)       Date:  2009-06-12       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.